—

GENERAL ATLANTIC, L.P.

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    12

  • Value ($000)

    $2,148,422

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001017645
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

DLOCAL

CL A
G29018101
$605.14M
28 %

46,656,695

---

CHIME

CL A
16935C109
$398.19M
19 %

21,259,683

---

XP, INC

CL A
G98239109
$391.58M
18 %

20,566,133

A
ALKT

ALKAMI

COM
01644J108
$240.34M
11 %

15,337,495

---

PHARVARIS

COM
N69605108
$226.88M
11 %

8,031,252

E
EWCZ

EUROPEAN WAX CENTER

CL A
29882P106
$75.78M
4 %

13,110,492

R
RVMD

REVOLUTION MEDICINES

COM
76155X100
$68.83M
3 %

707,791

N
NRIX

NURIX THERAPEUTICS

COM
67080M103
$63.58M
3 %

4,101,865

C
CNTA

CENTESSA PHARMACEUTICALS

ADS
152309100
$53.81M
3 %

1,354,830

---

RISKIFIED

CL A
M8216R109
$20.87M
1 %

5,324,998

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 12